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EXECUTIVE SUMMARY
Consumers, purchasers, policy-makers, and 
other stakeholders seek improved quality and 
affordability in our health care system.  A strong 
set of meaningful and usable performance 
measures is an essential tool in this pursuit.  
Currently, there are not enough of these  
measures, which are vital to:
•	 	Determine	whether	new	models	for	care	delivery		
and	payment	are	substantially	improving	health	
outcomes.
•	 	Help	consumers	choose	health	care	providers	and	
treatments.
•	 Engage	patients	in	decisions	about	their	care.
•	 	Give	providers	information	that	supports	their	
efforts	to	improve	care.
•	 	Enable	purchasers	and	health	plans	to	reward	
providers	based	on	quality	of	care	and	patient	
outcomes	rather	than	on	volume.	
To	meet	these	acute	needs,	more	ambitious	standards	
are	required	to	produce	the	kinds	of	quality	measures	
that	will	drive	meaningful	improvements	in	care.		
The	Consumer-Purchaser	Disclosure	Project	(CPDP)	
developed	10 criteria	for	meaningful	and	usable	
measures.		These	criteria	reflect	the	perspectives	of	
those	who	receive	and	pay	for	care,	and	should	be	used	
to	guide	the	development,	endorsement,	and	use	of	
performance	measures.		Performance	measures	must	
address	the	needs	of	those	whom	the	health	care	
system	is	intended	to	serve	and	those	who	pay	the	
price	for	poor	and	inefficient	care	—	consumers and 
purchasers.		These	criteria	are:
1.	 	Make	consumer	and	purchaser	needs	a	priority	in	
performance	measurement.	
2.	 	Use	direct	feedback	from	patients	and	their	
families	to	measure	performance.	
3.	 	Build	a	comprehensive	“dashboard”	of	measures	
that	provides	a	complete	picture	of	the	care	
patients	receive.	
4.	 	Focus	measurement	on	areas	of	care	where	the	
potential	to	improve	health	outcomes	and	increase	
the	effectiveness	and	efficiency	of	care	is	greatest.
5.	 	Ensure	that	measures	generate	the	most	valuable	
information	possible.	
6.	 	Require	that	all	patients	fitting	appropriate	clinical	
criteria	be	included	in	the	measure	population.
7.	 	Assess	whether	treatment	recommendations		
are	followed.
8.	 	De-emphasize	documentation	(check-the-box)	
measures.	
9.	 	Measure	the	performance	of	providers	at	all	levels	
(e.g.,	individual	physicians,	medical	groups,	ACOs).	
10.		Collect	performance	measurement	data	efficiently.
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	1	 	MAKE	CONSUMER	AND	PURCHASER	NEEDS	A	PRIORITY	IN	PERFORMANCE	
MEASUREMENT.
PROBLEM: 
Transforming	the	health	care	system	requires	that	
consumers	and	purchasers	take	a	larger	role	in	
improving	care	(i.e.,	patients	should	actively	participate	
in	their	care	and	be	able	to	select	providers	who	
meet	their	needs,	and	purchasers	should	offer	providers	
the	right	incentives	to	pursue	value	instead	of	
quantity	of	care).		Unfortunately,	only	a	small	number	
of	the	provider	performance	measures	currently	
available	or	in	use	supply	adequate	information	for	
consumers	and	purchasers	to	take	such	actions.
OPPORTUNITY:
Those	working	in	measurement	should	take	seriously	
the	requirements	described	below	and	involve	
consumers	and	purchasers	meaningfully	in	decisions	
related	to	measure	development,	endorsement,	and	
use	at	national	and	local/regional	levels	so	that	their	
needs	are	a	priority.	
2		USE	DIRECT	FEEDBACK	FROM		PATIENTS	AND	THEIR	FAMILIES	TO	
MEASURE	PERFORMANCE.
PROBLEM:
Most	measures	currently	in	use	are	overly	reliant	on	
information	generated	by	the	health	care	system	and	
do	not	capture	the	perspective	of	the	person	receiving	
health	services,	who	is	often	in	the	best	position	to	
evaluate	their	effectiveness.	
OPPORTUNITY:
More	measures	should	assess	outcomes	and	effective-
ness	of	care	as	experienced	by	patients	and	their	
families.		These	should	include	measures	of	patients’	
understanding	of	treatment	options	and	care	plans,	
and	their	feedback	on	whether	care	made	a	difference.		
Measure	developers	should	consider	how	patient-
reported	data	can	be	collected	and	used	efficiently	
and	effectively	as	health	plans	and	providers	connect	
electronically	with	an	increasing	number	of	their	
members/patients.	
3	 	BUILD	A	COMPREHENSIVE		“DASHBOARD”	OF	MEASURES	THAT	
PROVIDES	A	COMPLETE	PICTURE	OF	
THE	CARE	PATIENTS	RECEIVE.
PROBLEM:
All	too	often,	measures	have	focused	on	discrete	
treatment	processes	that	may	be	meaningful	to	
providers.		But	consumers	and	purchasers	are	asking	
for	a	wide	range	of	measures	that	capture	whether	
the	care	provided	reflected	the	patient’s	preferences,	
made	a	difference	for	that	patient,	and	was	delivered	
safely	and	efficiently.	
OPPORTUNITY:
A	comprehensive	dashboard	of	measures	will	make	it	
possible	to	assess	care	from	a	holistic	perspective,	
including	overall	effectiveness	and	efficiency	of	care.		
Such	a	dashboard	will	allow	us	to	hold	individual	
physicians,	accountable	care	organizations,	care	
teams,	hospitals,	and	other	providers	accountable	for	
how	well	they	care	for	their	patients	using	a		
multi-dimensional	view,	which	is	particularly		
important	for	those	with	multiple	chronic	conditions.	
The	table	on	the	next	page	shows	a	dashboard	that	
covers	the	full	spectrum	of	measures,	categorized	by	
the	three-part	aim	of	achieving	better	health,	better	
care,	and	lower	cost.1		We	recommend	that	if	a	
measure	set	cannot	address	a	specific	area	due	to	
current	data	or	other	technical	limitations,	a	clear	
course	should	be	charted	out	to	develop	methods	to	
fill	the	gap	over	time.	
Appendix	1,	on	page	10,	provides	an	example	of	how	
a	comprehensive	dashboard	of	measures	might	
look	for	maternity	care.		This	example	is	for		
illustrative	purposes	only,	and	we	recognize	that	
completing	this	dashboard	will	need	to	take	place	
over	time	as	the	measurement	infrastructure	for	
collecting	data,	including	from	electronic	health	
records,	becomes	more	robust.
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The	Patient-Centered	Measure	Dashboard
Better	Health
•  Clinical outcomes of treatment: 		
The	results	of	care	that	are	typically	
reported	by	a	doctor	or	other	clinician.	
Examples	of	clinical	outcomes	include	
treatment	complications,	health	
status,	morbidity,	mortality,		
preventable	readmissions,	and	
laboratory	determinations	of		
physiologic	values.
•  Patient-reported outcomes of 
treatment:		Assessments	by	patients	
of	whether	treatment	is	“working.”	
These	may	include	patients’	reports	of	
well-being,	resolution	of	pain,	
	improved	functioning.
Better	Care
•  Appropriateness of care:  
Underuse	and	overuse	of	diagnostic	
and	treatment	resources	—	which	are	
typically	assessed	by	the	process	
measures	in	use	today	—	and		
misdiagnosis.		Overuse	focuses	on	
whether	a	treatment	or	procedure	is	
appropriate	given	its	net	clinical	
benefit,	expenditure	of	resources,	and	
risk	to	the	patient,	e.g.,	exposure	to	
radiation	or	complications	from	
surgery.		Underuse	occurs	when	
patients	do	not	receive	medically	
necessary	care,	or	when	proven	health	
care	practices	are	not	followed.
•  Patient experience with care: 		
Evaluates	people’s	perspective	on	their	
experience	with	a	provider’s	care,		
i.e.,	how	well	doctors	communicate,	
know	their	patients,	coordinate	care,	
and	provide	quick	access	to		
appointments	and	care,	and	whether	
the	outcome	reflects	a	patient’s	
expectations.
•  Patient activation and engagement: 	
Evaluates	people’s	ability	and		
willingness	—	i.e.,	knowledge,	skills,	and	
confidence	—	to	manage	their	health	
and	health	care.		Providers	can	play	an	
important	role	in	developing	these	
qualities.
•  Care coordination and care  
transitions:		Assesses	how	well	
multiple	providers	work	together	to	
provide	seamless	care	to	a	patient,	
including	as	he	or	she	moves	from	one	
provider	or	care	setting	to	another,	or	
to	their	home.	
•  Effective use of health information 
technology (HIT) by patients and 
care providers:		Evaluates	whether	
HIT	improves	how	providers	deliver	
care	and/or	helps	patients	become	
more	engaged	in	their	care.
•  Patient safety:		Assesses	the		
presence	of	medical	errors	and	the	use	
of	processes	and	management	practices	
proven	to	promote	patient	safety		
(e.g.,	hand	hygiene,	medication	
reconciliation,	and	effective		
teamwork).
Lower	Cost
•  Total cost to and expenditures by  
(1) the patient; (2) the insurer; and 
(3) the health care system:
	 •	 Over	the	course	of	a	year
	 •	 Per	case	or	acute	episode
•  Efficiency of resource use:  
Includes	key	utilization	metrics	such	as	
emergency	department	visits,	hospital	
admissions,	and	readmissions.
Many of the identified measure types may fit into more than one section of the three-part aim. 
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4	 	FOCUS	MEASUREMENT	ON	AREAS	OF	CARE	WHERE	THE	POTENTIAL	
TO	IMPROVE	HEALTH	OUTCOMES	AND	
INCREASE	THE	EFFECTIVENESS	AND	
EFFICIENCY	OF	CARE	IS	GREATEST.
PROBLEM: 
Measure	development,	endorsement,	and	use	efforts	
don’t	always	focus	on	areas	of	care	with	the	greatest	
potential	to	improve	quality	and	use	resources	
effectively.		
OPPORTUNITY:
To	ensure	the	best	possible	return	on	investment,	
measure	sets	should:
•	 	Focus	on	areas	of	practice	with	high	frequency,	
high	cost,	wide	variation,	disparities	in	delivery,	
and/or	evidence	of	care	that	is	often	inappropriate.	
•	 	Address	leading	causes	of	morbidity,	mortality,		
and	disability.	
•	 	Assess	care	of	patients	with	multiple	chronic		
conditions,	a	leading	cost	driver.	
•	 	Cover	areas	identified	by	the	Institute	of	Medicine	
(IOM)	as	needing	significant	improvement:	safety,	
timeliness,	effectiveness,	efficiency,	equity,	and	
patient-centeredness.	
•	 	Meet	the	four	evaluation	criteria	used	by	the	
National	Quality	Forum	(NQF)2:	(1)	importance	to	
measure	and	report	—	especially	to	consumers	and	
purchasers,	(2)	scientific	acceptability	of	the	
measure	properties,	(3)	feasibility,	and	(4)	usability	
—	especially	by	consumers	and	purchasers.	
•	 	Include	measures	of	processes	of	care	only	if	they	
have	strong,	evidence-based	links	to	key	outcomes	
and	are	consistent	with	current	clinical	guidelines.
We	encourage	decision-makers	to	use	priorities	
identified	by	national	organizations	to	guide	work	in	
measurement.		Collectively,	these	priorities	cover	a	
breadth	of	areas	important	to	consumers	experiencing	
different	health	needs	(e.g.,	preventive,	acute	conditions,	
chronic	conditions).		Such	organizations	include:
•	 	The	federal	government’s	National Quality 
Strategy.
•	 	The	National Quality Forum	(NQF)	in	its		
prioritization	for	measure	development	and	
endorsement	of	the	top	20	conditions	with	a	high	
impact	on	Medicare.
•	 	The	National Priorities Partnership.
•	 	The	Measure Applications Partnership	(MAP),	
which	is	a	public-private	partnership	convened	by	
NQF	for	the	explicit	purpose	of	providing	input	to	
the	Department	of	Health	and	Human	Services	on	
the	selection	of	performance	measures	for	public	
reporting	and	performance-based	payment	
programs.
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5	 	ENSURE	THAT	MEASURES		GENERATE	THE	MOST	VALUABLE	
INFORMATION	POSSIBLE.	
PROBLEM:
Measures	are	not	always	collected	or	reported	in	the	
best	way	to	aid	decision-making	by	consumers,	
purchasers,	health	care	providers,	and	policy-makers.	
OPPORTUNITY:
A.  Use statistical standards that allow variations 
in care to show through.
Measure	developers	should	strike	a	balance	
between	correcting	for	measurement	errors	that	
inadvertently	classify	providers	as	“outliers”	and	
identifying	providers	that	are	actually	“outliers.”		
Measures	of	outcomes	and	resource	use	typically	
incorporate	statistical	techniques,	such	as	risk	
adjustment,	risk-stratification,	setting	standards	
for	reporting	through	confidence	levels,	and	so	
forth.		But	the	quest	for	a	“pure”	measure	—		
i.e.,	striving	for	perfection	over	practicality	—	
sometimes	washes	away	important	variations	in	
care.		Measures	may	be	over-adjusted	for	risk	
and/or	set	overly	stringent	statistical	standards,	
such	as	requiring	a	95%	certainty	that	the	results	
precisely	represent	a	provider’s	performance	on	a	
measure	or	labeling	most	providers	as	“average”	
when	large	variations	in	care	are	known	to	exist.	
This	is	problematic	because	patients	and		
purchasers	need	information	that	distinguishes	
performance	among	providers.	
B. Capture data for disparities analysis.  
Measures	should	be	stratified	by	demographic	
information,	such	as	race,	ethnicity,	language,	
gender,	disability,	and	socioeconomic	status.		This	
will	provide	important	information	to	help	identify	
and	address	disparities.
C.  Capture lab values and vital signs on a  
continuous scale.  
Actual	lab	values	and	vital	signs	that	represent	
valuable	intermediate	outcomes	in	treatment	
(e.g.,	LDL,	HbA1c,	blood	pressure)	should	be	
captured	so	that	the	exact	outcome	can	be	
collected.		Intermediate	outcome	measures	are	
often	structured	in	a	“yes”	or	“no”	form,	other-
wise	known	as	binary	measures.		An	example	is	
whether	a	patient	with	diabetes	has	“controlled	
blood	sugar,”	meaning	that	an	HbA1c	level	of	less	
than	8%	(or	7%	or	9%)	has	been	achieved.		
These	binary	measures	generally	ask	whether	the	
outcome	of	care	meets	a	threshold	based	on	
guidelines	or	opinions	that	are	often	subject	to	
change.		For	measures	like	these,	data	should	be	
captured	on	a	continuous	scale	so	that	thresholds	
can	be	adjusted	without	needing	to	recapture	the	
data	from	the	source.		For	example,	the	exact	
HbA1c	value	would	be	captured	(e.g.,	7.6%).	
Knowing	the	exact	value	of	the	outcome	for	each	
patient	allows:	
•	 Different	thresholds	to	be	set.	
•	 	Better	evidence	to	inform	clinical	guidelines	
and	identify	which	treatments	work	best	for	
which	patients.	
•	 Providers	to	focus	their	improvement	efforts.
D.  Combine process measures into an all-or-none 
composite.
Where	appropriate,	process	measures	should	be	
combined	to	create	composites	that	reflect	the	
set	of	processes	that	should	be	completed.		The	
composite	should,	for	a	given	condition,	be	based	
on	a	patient-centered	approach	(i.e.,	the	patient	
has	received	all	indicated	tests	and	treatments	
known	to	provide	significant	positive	health	
effects	for	their	condition).
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6	 	REQUIRE	THAT	ALL	PATIENTS		FITTING	APPROPRIATE	CLINICAL	
CRITERIA	BE	INCLUDED	IN	THE	
MEASURE	POPULATION.	
PROBLEM:
Sometimes	measures	are	constructed	to	allow	
patients	to	be	excluded	(using	“exclusions”	and	
“exceptions”)	from	the	measure	population	for	
poorly	defined	reasons.	This	can:
•	 	Lead	to	inappropriate	removal	of	patients	and	
promote	“gaming”	of	results.
•	 	Discourage	providers	from	engaging	patients.	
•	 	Mask	the	exact	reason	a	patient	is	removed,	
resulting	in	loss	of	transparency	and	valuable	
information.
•	 	Leave	room	for	interpretation,	thereby		
undermining	comparability.	
These	concerns	frequently	arise	when	the	reasons	
for	exclusions	and	exceptions	are	too	broad	and/or	
not	well	substantiated.		
An	example	of	an	exclusion	category	that	is	too	
broad	is	“patient	reasons;”	another	is	“system	
reasons.”		Use	of	such	ill-defined	categories	makes	it	
difficult	to	compare	performance	across	providers	
and	identify	trends	in	care.		Another	concern	is	that	
providers	can	remove	any	patient	who	does	not	
adhere	to	treatment	recommendations,	even	without	
a	strong	rationale.		Permitting	such	exclusions	does	
not	encourage	providers	to	do	the	important	work	of	
understanding	why	the	patient	isn’t	following	
recommendations	(e.g.,	patient	didn’t	comprehend	
the	importance,	is	concerned	about	medication	side	
effects,	etc.)	and	help	them	overcome	those	barriers.	
OPPORTUNITY:
To	avoid	these	problems,	reasons	for	exclusions		
and	exceptions	should	be	evidence-based, highly 
specific, and	explicitly defined.			
Examples	of	justifiable,	well-defined	reasons	for	
removing	a	patient	are:	
•	 	A	measure	of	whether	a	physician	provides	
mammography	screening	to	women	would	not	
include	women	who	have	had	their	breast	tissue	
removed.		These	women	do	not	require	the	
screening	and	therefore	should	not	be	included	in	
the	measure.
•	 	A	measure	of	whether	a	patient	received	or	filled	a	
prescription	would	not	include	a	patient	with	an	
allergy	to	the	medication.
7	 	ASSESS	WHETHER	TREATMENT	RECOMMENDATIONS	ARE		
FOLLOWED.	
PROBLEM:
Many	measures	in	use	today	are	process	measures	
that	ask	whether	a	provider	made	recommendations	
(e.g.,	prescribed	a	treatment,	ordered	a	test,	made	a	
referral)	in	accordance	with	clinical	guidelines.		But	
there	is	an	absence	of	measures	that	evaluate	
whether	the	provider,	the	patient’s	care	team,	and	
the	patient	took	these	recommendations	to		
completion.		Such	measures	would	reveal	whether	or	
not	what	should	have	happened	for	the	patient	
actually	happened.		They	are	also	critical	for	holding	
providers	accountable	for	coordinating	with	other	
providers,	and	engaging	patients	in	their	care.
OPPORTUNITY:
Measures	of	the	extent	to	which	a	physician’s	
recommendations	followed	clinical	guidelines	should	
be	paired	with	measures	of	completion	of	recommended	
treatment	(e.g.,	prescriptions	ordered	with	prescriptions	
filled,	tests	ordered	with	test	completion	and	results	
reported,	care	plan	developed	and	followed	by	the	
care	team,	etc.).	Shifting	to	a	patient-centered	
perspective	also	requires	that	measures	be	developed	
and	specified	to	allow	for	data	collection	from	the	
patient,	including	assessing	the	extent	to	which	
patients	understand	and	follow	recommended	care.	
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8	 	DE-EMPHASIZE	DOCUMENTATION	(CHECK-THE-BOX)	MEASURES.	
PROBLEM:
“Check-the-box”	measures	document	the	occurrence	
of	evaluation,	assessment,	counseling,	and	other	
steps	by	a	provider,	but	tell	us	little	about	the	quality	
of	care	provided	or	its	outcomes.		For	example:	
•	 	Current	measures	of	whether	a	clinician	provided	
counseling	on	smoking	cessation	—	an	important	
element	in	caring	for	individuals	and	populations	
—	don’t	reveal	how	effective	the	counseling	was.	
•	 	Measures	of	whether	a	physician	performed	an	
evaluation	of	a	patient’s	ability	to	walk	after	hip	
surgery	don’t	tell	us	whether	the	surgery	actually	
made	a	difference.		Rather,	we	need	the	results	of	
the	evaluation.	
In	fact,	there	is	a	poor	relationship	between	such	
measures	and	patient	outcomes.3		And	when	a	
measure	is	defined	as	a	simple	“check-the-box”		
(yes/no)	item,	it	is	often	subjective	and	easy	to	“game.”	
OPPORTUNITY:
•	 	Ask	the	patient	to	provide	feedback	on	the	quality	
of	the	interaction	with	the	physician	on	particular	
issues	(e.g.,	smoking	cessation);	and	in	the	longer	
term,	determine	whether	the	outcome	was	positive	
(e.g.,	whether	the	patient	quit	smoking).	
•	 	Report	the	results,	not	the	occurrence,	of		
evaluations	and	assessments.
9	 	MEASURE	THE	PERFORMANCE	OF	PROVIDERS	AT	ALL	LEVELS		
(E.G.,	INDIVIDUAL	PHYSICIANS,	
MEDICAL	GROUPS,	ACOs).
PROBLEM:
Many	argue	that	measures,	especially	those	involving	
patient	outcomes,	should	only	be	applied	at	a	higher	
level	in	the	chain	of	care	providers	(at	the	level	of	the	
practice	group,	the	ACO,	etc.)	rather	than	at	the	level	
of	the	individual	physician.		But	consumers	need	to	
select	individual	physicians	to	be	a	part	of	their	care	
team,	even	where	team-based	practice	occurs.	
OPPORTUNITY:
Performance	should	be	measured	at	all	levels,	
including	the	individual	physician	level,	when	sample	
sizes	are	sufficient.		Consider	that:
•	 	Individual	physicians	make	decisions	that	control	
87%	of	personal	health	spending.4	
•	 	Data	on	practice	groups	do	not	always	well		
represent	an	individual	physician’s	performance.		
The	way	physicians	within	the	same	group	care	for	
their	patients	can	vary	significantly,	and	individual	
physicians	greatly	impact	the	care	that	a	patient	
receives.5		
Even	where	sample	sizes	are	small,	performance	
information	can	be	very	valuable	to	physicians	
themselves	to	help	them	accelerate	quality		
improvement.		While	patients	and	system	factors	
related	to	the	physician’s	practice	setting	also	affect	
clinical	performance	and	its	outcomes,	we	should	
measure	performance	and,	once	adjusted	for	critical	
patient	risk	factors,	attribute	it	jointly	to	individual	
physicians,	their	team,	and	the	system	they	practice	
in.		In	other	words,	we	subscribe	to	a	concept	of		
shared accountability.
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10	 	COLLECT	PERFORMANCE		MEASUREMENT	DATA	EFFICIENTLY.	
PROBLEM:
Providers	often	raise	issues	about	the	amount	of	
effort	it	takes	for	them	to	collect	performance	data.
OPPORTUNITY:
Ideally,	performance	measures	should	be	based	on	
the	same	data	that	clinicians	use	—	or	should	use	—		
to	care	for	their	patients.		Specifications	should	call	
for	measures	to	be	populated	with	electronic	data	
that	are	collected	and	used	for	patient	care,	including	
patient-reported	outcomes.		Where	the	data	do	not	
exist	in	electronic	form	today,	there	should	be	a	
clearly	articulated	path	for	future	electronic		
collection	and	submission	of	data	by	increased	
reliance	on	electronic	health	records,	as	well	as	
broader	efforts	by	specialty	societies,	hospitals,	
nursing	homes,	and	others	to	collect	electronic	data.		
Measure	developers	should	also	consider	basing	
measures	on	administrative	data	when	possible.		
Administrative	data	will	continue	to	be	an	important	
source	of	information	on	the	services	provided,	even	
when	widespread	adoption	of	EHRs	occurs.	
However,	the	desire	to	avoid	encumbering	providers	
with	additional	data	collection	requirements	must	be	
balanced	against	the	tremendous	need	that	patients,	
purchasers,	and	other	stakeholders	have	for		
information.		Patients	face	significant	burdens	every	
day	when	trying	to	navigate	the	health	care	system,	
including	choosing	a	provider,	trying	to	find		
affordable	care,	and	determining	what	treatment	will	
be	best	for	them.		At	another	level,	purchasers	and	
payers	need	information	to	help	them	reward	
higher-performing	providers	who	generate	better	
quality	and	value	of	care.	
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Appendix	1:		
Example	of	a	Comprehensive	Dashboard	of	Measures	for	Maternity	Care
PRENATAL
(Outpatient	setting)
DELIVERY
(Inpatient	setting)
POSTPARTUM
(Inpatient	and	outpatient	setting)
PATIENT-REPORTED OUTCOMES OF TREATMENT
•	 	Health	status	after	delivery		
(e.g.,	presence	of	pain	and/or	
infection,	presence	of	postpartum	
depression)	4-6	weeks	post	
discharge*
•	 	Effective	treatment	for	maternal	
morbidities	(e.g.,	pain	and/or	
infection,	postpartum	depression)*	
PATIENT EXPERIENCE WITH CARE
•	 	Patient	experience	of	care*	
(e.g.,	CAHPS	modified	for		
maternity	care)
PATIENT ENGAGEMENT
•	 	Patient	receives	high-quality,	
understandable	information	about	
impact	of	interventions		
(e.g.,	C-section,	induction)*
•	 	Effective	use	of	shared		
decision-making*	
•	 	Patients	with	previous	C-section	are	
offered	a	VBAC	if	available	(either	
directly	or	through	referral)*
•	 	Patients	are	offered	a	range	of	
options	for	pain	management	(e.g.,	
non-pharmacological	options	vs.	
pain	medications	such	as	epidurals,	
spinal	analgesia,	narcotics,	etc.)*	
•	 	In	active	labor,	mother	has	right	to	
self-determination	(i.e.,	provider	
follows	patient’s	wishes)	
CLINICAL OUTCOMES OF TREATMENT
•	 	Healthy	term	newborns
•	 	Term	newborns	with	hospital-	
acquired	conditions	
•	 	Maternal	complications	(e.g.,	
hemorrhage,	infections,	DVT)
•	 Exclusive	breastfeeding
•	 	Maternal	and	newborn	readmissions
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Appendix	1:		
Example	of	a	Comprehensive	Dashboard	of	Measures	for	Maternity	Care
PRENATAL
(Outpatient	setting)
DELIVERY
(Inpatient	setting)
POSTPARTUM
(Inpatient	and	outpatient	setting)
CARE COORDINATION AND TRANSITIONS
•	 	Patient	preferences	shared	with	
entire	care	team
•	 	Information	exchange	between	
patient’s	primary	physician	and	
delivering	provider	on	patient’s	
health	needs	
•	 	Adherence	to	patient	preferences*
•	 	Prenatal	record	available	at	the	
birth	site	(should	include	patient’s	
delivery	preferences)
•	 	Maternity	care	record	(including	
patient-reported	outcomes)	shared	
with	patient’s	primary	care	physician	
(e.g.,	patient	with	gestational	
diabetes	would	benefit	from	this	
sharing	of	information)
APPROPRIATENESS OF CARE (OVERUSE, UNDERUSE)
•	 	Screening	for	domestic	abuse	and	
substance	abuse
•	 	Advice	and	appropriate	referrals	for	
those	who	are	smoking	and/or	
engaging	in	substance	abuse
•	 	Patient	receives	selected	essential		
prenatal	care1	
•	 	Spontaneous	births	and	labor		
(a	composite)	(e.g.,	no	induced	labor,	
augmented	labor,	assisted	delivery,	
or	Cesarean	section)	
•	 VBAC	for	low-risk	women
•	 Low-risk	C-section	in	first	births	
•	 	Elective	delivery	between	37	and	39	
weeks	
•	 Elective	induction	under	41	weeks
•	 Use	of	episiotomy	
•	 	Healthy	newborns	admitted	to		
the	NICU
•	 	Skin-to-skin	contact	in	the	first	
hours	after	birth
TOTAL COST TO AND EXPENDITURES BY (1) THE PATIENT; (2) THE INSURER;  
AND (3) THE HEALTH CARE SYSTEM/EFFICIENCY OF RESOURCE USE
•	 Cost	of	prenatal	care •	 	Cost	of	delivery-associated	care	
(e.g.,	physician,	hospital,	midwife,	
birth	center)	—	covering	episode	of	
care	for	mother	and	baby
•	 Length	of	stay	(mother	and	baby)
•	 	Cost	of	newborn		
(prior	to	hospital	discharge)
•	 	Hospital	readmission		
(mother	or	baby)
Note:	Identified	elements	of	maternity	care	can	apply	to	more	than	one	domain.
*Elements	that	could	be	captured	through	a	patient	survey.
1	For	example,	prenatal	care	should	begin	within	the	first	ten	weeks	and	include	antenatal	corticosteroids	for	accelerating	fetal	lung	
maturation	for	women	at	risk	of	preterm	birth.
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